Last quarter (Q2 2022), Genflow Biosciences Plc's total revenue was £―, a decrease of ― from previous quarter. In Q2, Genflow Biosciences Plc's net income was £―. See Genflow Biosciences Plc’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21
Total Revenue	-	-	-
Cost of Revenue	-	-	-
Gross Profit	-	-	-
Operating Expense	-	£ 1.82M	£ 938.10K
Operating Income	-	£ -1.82M	£ -938.10K
Net Non Operating Interest Income Expense	-	£ -382.00	£ 99.00
Other Income Expense	-	£ -487.29K	-
Pretax Income	-	£ -1.34M	£ -988.20K
Tax Provision	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-
Net Income Common Stockholders	-	£ -1.34M	£ -988.20K
Basic EPS	-	-	-
Diluted EPS	-	-	-
Basic Average Shares	-	£ 292.51M	£ 244.57M
Diluted Average Shares	-	£ 292.51M	£ 244.57M
Dividend Per Share	-	-	-
Total Operating Income As Reported	-	-	-
Reported Normalized Basic E P S	-	-	-
Reported Normalized Diluted E P S	-	-	-
Rent Expense Supplemental	-	-	-
Total Expenses	-	£ 1.82M	£ -938.10K
Net Income From Continuing And Discontinued Operation	-	£ -1.34M	£ -988.20K
Normalized Income	-	£ -1.08M	£ -800.44K
Interest Expense	-	-	-
EBIT	-	£ -1.33M	£ -988.10K
EBITDA	-	£ -1.33M	£ -988.10K

Currency in GBP

Genflow Biosciences Plc Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing